Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 1330Neoplasms 984Carcinoma, Non-Small-Cell Lung 860Prostatic Neoplasms 728Colorectal Neoplasms 665Lung Neoplasms 551Leukemia, Myeloid, Acute 476Neoplasm Metastasis 435Pancreatic Neoplasms 418Carcinoma, Hepatocellular 408Multiple Myeloma 396Ovarian Neoplasms 391Stomach Neoplasms 380Recurrence 364Squamous Cell Carcinoma of Head and Neck 324Melanoma 294Brain Neoplasms 289Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 273Glioblastoma 265Head and Neck Neoplasms 264Precursor Cell Lymphoblastic Leukemia-Lymphoma 255Endometrial Neoplasms 233Lymphoma 228Rectal Neoplasms 223Esophageal Neoplasms 222Sarcoma 214Carcinoma, Renal Cell 204Colonic Neoplasms 194Lymphoma, Non-Hodgkin 191

Interventions

Paracentesis 1Biopsy 1Atovaquone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × Ovarian High Grade Serous Adenocarcinoma × Clear all
NCT05998135 2025-09-11

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Emory University

Phase 2 Recruiting
28 enrolled
Gynecologic

Ovarian High Grade Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡